Normal saline (0.9% sodium chloride solution)- Stage 2

OTHER2 trials

Sponsors

SK Bioscience Co., Ltd.

Conditions

COVID-19 (Healthy Volunteers)

Phase 1

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

CompletedNCT04742738

SK Bioscience Co., Ltd.COVID-19 (Healthy Volunteers)

Start: 2021-01-20End: 2022-07-07Updated: 2023-04-18

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)

SK Bioscience Co., Ltd.COVID-19 (Healthy Volunteers)

Start: 2021-02-03End: 2022-06-30Updated: 2022-05-10

Related Papers

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.

2022-07-2286 citations

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.

2021-04-19296 citations